The information is for the following 3 questions. In a clinical trial, 12 out of 600 patients taking a prescription drug complained of flulike symptoms. Suppose that it is known that 2.5% of patients taking competing drugs complain of flulike symptoms. Test if the prescription drug cause less flulike symptoms as a side effect at the α=0.02 level of significance.
Estimate the right boundary of the 98% C.I. of the population proportion. All answers must be rounded to 4 decimal places |
Solution :
Given that,
n = 12
x = 600
Point estimate = sample proportion = = x / n = 12 / 600 = 0.020
1 - = 0.980
Z= 2.054
Margin of error = E = Z * (( * (1 - )) / n)
= 2.054 * (((0.020 * 0.980) / 600)
= 0.0117
Right boundary = + E = 0.020 + 0.0117 = 0.0317
The information is for the following 3 questions. In a clinical trial, 12 out of 600...
In a clinical trial, 20 out of 600 patients taking a prescription drug complained of flulike symptoms. Suppose that it is known that 5.5% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that less than 5% of this drug's users experience flulike symptoms as a side effect at the α=0.04 level of significance? -What is the P-value of the test result? -What is the test statistics? -What is the critical value? -What is...
In a clinical trial, 19 out of 892 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.9% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 1.9% of this drug's users experience flulike symptoms as a side effect at the alpha equals α=0.05 level of significance?
In a clinical trial, 20 out of 600 patients taking a prescription drug complained of flulike symptoms. Suppose that it is known that 5.5 % of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that less than 5 % of this drug's users experience flulike symptoms as a side effect at the α=0.04 level of significance? A. Construct the null hypothesis and the alternative hypothesis. B. What is the P-value of the test result?...
In a clinical trial, 23 out of 888 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.1% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.1% of this drug's users experience flulike symptoms as a side effect at the a = 0.1 level of significance? of the population size, and the sample the requirements for testing the hypothesis Because np 10, the...
In a clinical trial, 24 out of 893 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.4% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.4% of this drug's users experience flulike symptoms as a side effect at the a=0.1 level of significance? V 5% of the population size, and the sample the requirements for testing the hypothesis satisfied. Because np. (1-P)...
In a clinical? trial, 28 out of 850 patients taking a prescription drug complained of flulike symptoms. Suppose that it is known that 2.1?% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.1?% of this? drug's users experience flulike symptoms as a side effect at the alpha equals 0.1 level of? significance? What are the null and alternative? hypotheses? Upper H 0?: p ? nothing versus Upper H 1?: p...
In a clinical trial, 23 out of 870 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.4% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.4% of this drug's users experience flulike symptoms as a side effect at the α=0.05 level of significance? Because np0(1−p0)=__?__ ▼ < > ≠ = 10, the sample size is ▼ less than greater than 5% of...
In a clinical trial, 18 out of 858 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.8% of patients taking competing drugs complain of ulike symptoms. Is there sufficient evidence to conclude that more than 1.8% of this drug's users experience flulike symptoms as a side effect at the a=0.05 level of significance? 5% of the population size, and the sample V the Because npo (1-P) - 10, the sample size is...
X 10.2.17-T Question Helo In a clinical trial, 27 out of 866 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 26% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.6% of this drug's users experience flulike symptoms as a side effect at the x = 0.05 level of significance? Because npo (1-P) - 866 = 10, the sample size is less than...
In a clinical trial, 22 out of 897 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 2.1% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 2.1% of this drug's users experience flulike symptoms as a side effect at the a = 0.01 level of significance? less than 5% of the population size, and the sample can be reasonably assumed to be random,...